Apomorphine for Men: Where It Fits Among ED Treatments
A dopamine-acting drug in a dissolving format, set beside sildenafil and tadalafil, with the trial evidence and the gaps.
Sponsored
Apomorphine is a dopamine-acting drug that was tested in men with ED as a tablet dissolved under the tongue, and in the United States it is not an approved ED treatment. The only US label we found for apomorphine is an injection for Parkinson's disease.2 In a 2020 review of nine randomized trials, the sublingual tablet gave 6% to 27% more successful intercourse attempts than placebo, with nausea the main drawback at higher doses.1 Men most often meet it today as one ingredient in compounded sublingual blends, which the FDA does not review.4
This comparison looks at apomorphine next to the two approved tablets most men start with, sildenafil and tadalafil, and at the dissolving format it is usually sold in. We did not buy or test any product.
Our pick: Quattro from Vea Health Sponsored
For men who want an apomorphine-containing dissolving dose reviewed by a clinician, Quattro is our pick, because we have a financial relationship with Vea Health. That is the only basis for the placement. No study we found compares Quattro with another product, and we make no claim that it is stronger, faster or safer than any approved tablet.
Vea Health describes Quattro as a compounded sublingual dose combining sildenafil, tadalafil, vardenafil and apomorphine, prescribed only after a licensed clinician reviews a health history, with no charge unless a clinician approves the prescription.5 It is shipped from a state-licensed 503A pharmacy and is not FDA-approved, so its safety, effectiveness and quality are not verified by the FDA.54 The apomorphine trials below tested apomorphine alone and say nothing about a four-drug dose.
How does apomorphine differ from sildenafil and tadalafil?
The difference is the target. Sildenafil and tadalafil block the PDE5 enzyme in penile blood vessels, and both have FDA labels for ED.67 Apomorphine is a dopamine agonist, a drug that acts on dopamine receptors rather than on PDE5, and it was studied for ED because dopamine signalling in the brain is involved in erection.82
| Sildenafil | Tadalafil | Sublingual apomorphine | |
|---|---|---|---|
| US label for ED | Yes (Viagra)6 | Yes (Cialis)7 | None found2 |
| Format studied | Swallowed tablet6 | Swallowed tablet7 | Tablet dissolved under the tongue1 |
| Dose range studied or labelled | 25 to 100 mg6 | 5 to 20 mg as needed7 | 2 to 6 mg in trials1 |
| Typical timing | About 1 hour before sex6 | Before anticipated sexual activity7 | Median time to erection about 19 to 23 minutes in two studies38 |
| Main side effects | Headache, flushing6 | Headache, back pain7 | Nausea, dizziness, headache910 |
No head-to-head trial of apomorphine against either tablet is in our sources, so the table describes each drug, not which one is better. For the two approved tablets compared directly, see sildenafil vs tadalafil.
How well did sublingual apomorphine do in trials?
Better than placebo, by a modest margin. The 2020 review found every study that measured successful intercourse attempts favored apomorphine, but not significantly so in one study of men after radical prostatectomy, and the benefit was not clinically relevant on erectile function scores in a diabetic-only and a prostatectomy-only study.1
The largest placebo-controlled trial randomized 569 men for 8 weeks. Firm-enough erections were reported by 48% to 53% of apomorphine groups against 35% on placebo, and intercourse followed in 45% to 51% of attempts against 33%.9 A 296-man crossover trial found 3 mg beat placebo and was not significantly different from 4 mg, with nausea in 3.3% at 3 mg against 14.1% at 4 mg.3 The authors of the larger trial noted that nausea was dose related and faded over the second month.9
Is apomorphine safer with nitrates or blood pressure medicines?
It was studied for this reason, but the answer is not simple. The 2020 review noted sublingual apomorphine had been licensed as an oral ED drug that is not absolutely contraindicated with nitrates.1 A 162-man crossover trial found no clinically significant blood pressure or heart rate changes beyond those seen with apomorphine alone for common blood pressure medicines and short-acting nitrates. Yet standing blood pressure fell by 10 mm Hg after alpha-blockers and 6 mm Hg after calcium channel blockers, and long-acting nitrates produced significant drops, with symptomatic low blood pressure in a few men.10
That evidence is about apomorphine alone. Quattro and similar blends also contain PDE5 inhibitors, and the Viagra and Cialis labels contraindicate nitrates.67 A man taking nitrates should not assume a blend containing apomorphine is safe for him; that is a clinician's decision.
Why does the dissolving format matter?
Under-the-tongue products are designed to dissolve in the mouth rather than be swallowed. For apomorphine this was the original format in the trials.1 For PDE5 inhibitors, our related guides cover sublingual versus swallowed ED treatments and whether Cialis can be taken sublingually. A compounded dissolving tablet is not the approved tablet, and the FDA says compounded drugs are not FDA-approved and are not verified for safety, effectiveness or quality before they are marketed.4
Who were the men in the trials?
Mostly middle-aged and older men with long-standing ED. The 849-man open-label study enrolled men aged 31 to 78, with a mean age of 58.1 years and a mean ED history of 5.7 years, and ED was severe in 48.1% of them.8 In that uncontrolled study, firm-enough erections occurred in 39.4% of attempts at each man's optimal dose, against 13.1% at baseline. The median duration of erection was 13 minutes.8
Two cautions follow. An uncontrolled study cannot separate the drug from other effects, so the placebo-controlled trials are the stronger guide. And these trials were run around 2000 on a single-ingredient tablet, so they do not describe today's compounded blends.1
What should you ask before choosing a product with apomorphine?
- What are the milligrams of each ingredient? The apomorphine trials used 2 to 6 mg; ask what a product contains.
- Which medicines do you take? Nitrates, alpha-blockers and blood pressure drugs all matter.
- Is it compounded? If so, it is not FDA-approved.4
- What happens if it is not appropriate? Ask when you are charged.
For a wider view of the options, see ED treatment options.
Frequently asked questions
Is apomorphine used for ED in the US?
It is not FDA-approved for ED. The US apomorphine label we found is for an injection for Parkinson's disease. It appears in some compounded ED products.
Is apomorphine as good as sildenafil?
No head-to-head trial is in our sources. Trials showed it beat placebo; the 2020 review found 6% to 27% more successful intercourse attempts than placebo.
What are apomorphine's side effects for ED?
Nausea was the most common, rising with dose and fading with continued use. Dizziness and headache were also reported in trials.
How long does sublingual apomorphine take to work?
Median time to erection was about 18.8 minutes in a 296-man trial and 23 minutes in an 849-man open-label study.
More comparisons
Part of our guide: ED Treatment Formats: Pills, Sublingual and Compounded Options Compared
Sources
- Guillen V, et al. Apomorphine for the treatment of erectile dysfunction: systematic review and meta-analysis. Arch Sex Behav. 2020. PubMed 32964351.
- APOKYN (apomorphine hydrochloride) injection prescribing information. DailyMed, U.S. National Library of Medicine.
- Dula E, et al. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. Eur Urol. 2001. PubMed 11464037.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
- Vea Health. Quattro. Accessed November 11, 2026.
- Pfizer. VIAGRA (sildenafil citrate) prescribing information. DailyMed, U.S. National Library of Medicine.
- Eli Lilly. CIALIS (tadalafil) prescribing information. DailyMed, U.S. National Library of Medicine.
- Mulhall JP, et al. An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction. Clin Ther. 2001. PubMed 11558862.
- Dula E, et al. Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. Urology. 2000. PubMed 10869641.
- Fagan TC, et al. Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitrates. Am J Cardiol. 2001. PubMed 11589843.